Marketing is likely to be underway now. The first line of the quarterly reads: "Samples of flotation concentrates for initial marketing assessment have been completed". On page 2, it says: "Flotation testing has delivered the required mass of concentrates to commence initial marketing assessment".
It seems like they wanted to get the product ready first and then have talks, rather than the other way around. That also suggests that AXE has sounded out the market and made a product to market, before going forth with marketing.
As picked up in this thread, the timing of the quarterly is interesting and may suggest more news to come in coming weeks. Of course, this is purely speculative.
However, would not be surprised if that happens, AXE has a habit of releasing high impact announcements out of nowhere.
The quarterly is positive in terms of content - everything is progressing well (albeit slow) and it looks like GA is confident that 99.9% can be achieved (sooner or later). Just another one of AXE's patented "yeah everything is going along fine and we are sticking to our strategy of checking all the boxes".
Nevertheless, I am disappointed by the fact that AXE is still on its journey, and not at the finish line in certain respects such as purity and bulk flotation (which was suppose to be completed months ago).
Somewhat understandable as people have been away + Christmas holidays etc., but would be nice to have updated timeframes to market in a timely manner.
- Forums
- ASX - By Stock
- AXE
- q out early - why?
q out early - why?, page-12
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AXE (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.0¢ |
Change
-0.020(5.26%) |
Mkt cap ! $91.74M |
Open | High | Low | Value | Volume |
39.5¢ | 39.5¢ | 35.5¢ | $186.8K | 508.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 39610 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 7888 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 39610 | 0.355 |
9 | 79399 | 0.350 |
1 | 11000 | 0.345 |
4 | 111450 | 0.340 |
5 | 50350 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 7888 | 1 |
0.390 | 51464 | 4 |
0.395 | 50496 | 3 |
0.400 | 138658 | 6 |
0.405 | 176582 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online